Outcome of Early Versus Late Surfactant Therapy in Preterm Neonates with Respiratory Distress Syndrome at a Tertiary Care Centre

dc.contributor.authorDhale, Shrutien_US
dc.contributor.authorChavan, Priyaen_US
dc.contributor.authorKulkarni, Aneeshen_US
dc.contributor.authorNarwate, Prachetaen_US
dc.date.accessioned2023-07-21T11:26:08Z
dc.date.available2023-07-21T11:26:08Z
dc.date.issued2022-12
dc.description.abstractBackground: Respiratory distress syndrome (RDS) or hyaline membrane disease (HMD), has been recognized as the most common co-morbidity of prematurity. Prematurity and RDS largely contribute to early neonatal morbidity and mortality. With adequate antenatal steroid and early continuous positive airway pressure, early surfactant therapy improve survival outcome.Material & Methods:Prospective interventional study included newborns with prematurity 28-36 weeks(GA) with clinical Respiratory distress syndrome and birth weight(BW)>650 gm. All subjects were preferably provided early surfactant therapy (within 2hours after birth). Surfactant (survanta) was delivered by INSURE technique (Intubate- Surfactant administration- Extubate) and only those who required further respiratory support were ventilated. Records on birth weight, gestational age, timing of therapy (early/late), sepsis, complications, and survival/death outcome were collected and data was analyzed using SSPS version 20 software.Results:Out of 76 neonates (42 male, 34 female), 46 received early surfactant therapy and 30 obtained it late; Although mortality was observed with both early(36.66%) and late therapy(63.33%), there was significantly higher survival with early therapy. higher mortality occurred in lower Birth weight(LBW) /Gestational age (GA) subgroups. Culture positive sepsis was found in 52.6% with higher association with late therapy . Hypotension was most common complication with late intervention , whereas there was no difference for pulmonary haemorrhage or apnea.Conclusion:Early surfactant administration improved survival with minimal complications in RDS except for extremely premature/LBW babies.en_US
dc.identifier.affiliationsAssociate Professor, Department of Paediatrics Grants Government Medical College Mumbai, Maharashtra, India. Email: shruti.millenium@gmail.com Orcid ID: 0000-0003-2097-7583en_US
dc.identifier.affiliationsJunior Resident, Department of Paediatrics Grants Government Medical College Mumbai, Maharashtra, India. Email: vinupriya0726@gmail.com Orcid ID: 0000-0003-1459-8544en_US
dc.identifier.affiliationsJunior Resident, Department of Paediatrics Grants Government Medical College Mumbai, Maharashtra, India. Email: kulkarni.aneesh100@gmail.com, Orcid ID: 0000-0001-8870-873Xen_US
dc.identifier.affiliationsJunior Resident, Department of Paediatrics Grants Government Medical College Mumbai, Maharashtra, India. Email: prachetanarwate@gmail.com, Orcid ID: 0000-0001-8452-4351en_US
dc.identifier.citationDhale Shruti, Chavan Priya, Kulkarni Aneesh, Narwate Pracheta. Outcome of Early Versus Late Surfactant Therapy in Preterm Neonates with Respiratory Distress Syndrome at a Tertiary Care Centre. Annals of International Medical and Dental Research. 2022 Dec; 8(6): 7-14en_US
dc.identifier.issn2395-2822
dc.identifier.issn2395-2814
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/220061
dc.languageenen_US
dc.publisherScholars Publisheren_US
dc.relation.issuenumber6en_US
dc.relation.volume8en_US
dc.source.urihttps://doi.org/10.53339/aimdr.2022.8.6.2en_US
dc.subjectPreterm neonatesen_US
dc.subjectRDSen_US
dc.subjectSurfactant therapyen_US
dc.subjectEarly administrationen_US
dc.subjectSurvival outcome.en_US
dc.titleOutcome of Early Versus Late Surfactant Therapy in Preterm Neonates with Respiratory Distress Syndrome at a Tertiary Care Centreen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AIMDR2022v8n6p7.pdf
Size:
295.22 KB
Format:
Adobe Portable Document Format